Ganglion cell maturation in peripheral neuroblastic tumours of children
- 1 May 2022
- journal article
- research article
- Published by Dustri-Verlgag Dr. Karl Feistle in Clinical Neuropathology
- Vol. 41 (05), 101-113
- https://doi.org/10.5414/np301450
Abstract
Peripheral neuroblastic tumours of neural crest origin are the most frequent solid neoplasms outside the CNS in children. Neuroblastoma/ganglioneuroblastoma/ganglioneuroma have a natural evolution of histological differentiation over time. Together with mitosis-karyorrhexis index and patient age (International Neuroblastoma Pathology Classification criteria), ganglion cell maturation determines grading and prognosis. Maturation presently is usually assessed only histologically. Immunocytochemical tissue markers defining neuroblast maturation in fetal CNS were here applied to peripheral neuroblastic tumours arising in the adrenal medulla or sympathetic chain. Paraffin sections of resected tumours of 4 toddlers were examined using antibodies demonstrating neuronal identity and maturation: MAP2; synaptophysin; chromogranin-A; NeuN; keratan sulfate (KS); glutamate receptor antibody (GluR2). Synaptophysin, normally a late marker of neuroblast differentiation, was the earliest expressed in neuroblastoma. Others include: Ki67; S-100 beta protein; vimentin; nestin; alpha-Bcrystallin; neuroblastoma marker PHOX2B. Various degrees of ganglion cell maturation were demonstrated by MAP2, chromogranin, synaptophysin, KS, and GluR2; NeuN was uniformly negative, consistent with sympathetic neurons. KS was sparsely distributed within the tumours in interstitial tissue, within processes of some non neuronal cells, and adherent to somata and proximal neuritic trunks. Neoplastic ganglion cells with multiple nuclei matured similar to mono-nuclear forms. PHOX2B did not distinguish maturational stages. S-100 beta protein and alpha-B-crystallin labeled Schwann cells, especially Schwannian ganglioneuroma. Immunocytochemical markers of neuroblast maturation in fetal brain also are useful in peripheral neuroblastic tumours, providing greater precision than histology alone. The most practical are MAP2, chromogranin-A, and synaptophysin. Prognosis and choice of treatment including chemotherapy might be influenced.Keywords
This publication has 20 references indexed in Scilit:
- Clinical neuropathology practice guide 5-2013: markers of neuronal maturationClinical Neuropathology, 2013
- PHOX2B ImmunolabelingThe American Journal of Surgical Pathology, 2012
- The clinicopathologic spectrum of focal cortical dysplasias: A consensus classification proposed by an ad hoc Task Force of the ILAE Diagnostic Methods Commission1Epilepsia, 2010
- Balloon cells in human cortical dysplasia and tuberous sclerosis: isolation of a pathological progenitor-like cellActa Neuropathologica, 2010
- The evolutionary origin of the vertebrate neural crest and its developmental gene regulatory network – insights from amphioxusZoology, 2009
- The evolution and elaboration of vertebrate neural crest cellsCurrent Opinion in Genetics & Development, 2008
- Evolution of the neural crest viewed from a gene regulatory perspectivegenesis, 2008
- Congenital Muscle Fiber-Type Disproportion in a Patient With Congenital Central Hypoventilation Syndrome Due to PHOX2B MutationsJournal of Child Neurology, 2008
- New genes in the evolution of the neural crest differentiation programGenome Biology, 2007
- Revision of the International Neuroblastoma Pathology ClassificationCancer, 2003